Search results

Press Release

Altasciences Completes Successful Phase I Trial of Ischemix’ Novel Compound for Treatment of Traumatic Brain Injury (TBI)

Aug 28, 2023

• Clinical Trials

ISSUE NO. 35 — Critical Considerations for the Safe and Compliant Manufacture of Highly Potent Drugs

Aug 24, 2023

• Manufacturing and Analytical Services

ISSUE NO. 34 — Toxicokinetics, Pharmacokinetics, and Pharmacodynamics

Aug 22, 2023

• CRO Services

ISSUE NO. 12 — Antisense Oligonucleotides

Mar 6, 2020

• Bioanalysis

ISSUE NO. 7 — Understanding the Intrinsic and Extrinsic Factors that Alter Drug Exposure and Toxicity

Jan 1, 2019

• Clinical Trials

Scientific Publication

First-in-Human Solution for Small and Large Molecules

Mar 18, 2024

• Clinical Trials

Press Release

Altasciences Receives 2023 CRO Leadership Award for Capabilities

May 4, 2023